RT @DoctorKruz: Como dijo Fernán Quirós esta es una enfermedad de ciudades. Aquellas con seroprevalencias del 15 al 20 % (NYC, Madrid) esta…
RT @DoctorKruz: Como dijo Fernán Quirós esta es una enfermedad de ciudades. Aquellas con seroprevalencias del 15 al 20 % (NYC, Madrid) esta…
RT @DoctorKruz: Como dijo Fernán Quirós esta es una enfermedad de ciudades. Aquellas con seroprevalencias del 15 al 20 % (NYC, Madrid) esta…
RT @DoctorKruz: Como dijo Fernán Quirós esta es una enfermedad de ciudades. Aquellas con seroprevalencias del 15 al 20 % (NYC, Madrid) esta…
Como dijo Fernán Quirós esta es una enfermedad de ciudades. Aquellas con seroprevalencias del 15 al 20 % (NYC, Madrid) estan en fase de salida y no tienen rebrotes. En esto baso mi optimismo. Buen Domingo amigos. https://t.co/ZqYcuLqmRC
RT @takanoriida: 山中先生HPで紹介されていたLancet論文のスペインの6万人規模抗体検査。抗体陽性率4%、抗体陽性者の2割が事前PCR陽性、抗体陽性者の3割が無症状、事前PCR陽性の9割が抗体陽性。直近の大規模日本人調査が求められるところ。 https://…
山中先生HPで紹介されていたLancet論文のスペインの6万人規模抗体検査。抗体陽性率4%、抗体陽性者の2割が事前PCR陽性、抗体陽性者の3割が無症状、事前PCR陽性の9割が抗体陽性。直近の大規模日本人調査が求められるところ。 https://t.co/HVO3xvehUN
Is school reopening bad? What do we know already? @leorahorwitzmd is looking for reliable data. Read the thread. Children possible don't transmit as much as adults
RT @Eng_mtaher: طال عمرك دكتور تغريدات كثيره جدا وحوارات اكثر مع الاصدقاء حول هذا الموضوع ومنذ زمن بعيد انا لست عالم بالفيروسات او دكتور…
RT @MaxCRoser: What share of Spain’s population has antibodies for the new coronavirus? Even in Spain – one of the very worst-hit countrie…
Similar resultado al estudio español https://t.co/F7LpdAKM6a
RT @MaxCRoser: What share of Spain’s population has antibodies for the new coronavirus? Even in Spain – one of the very worst-hit countrie…
RT @MaxCRoser: What share of Spain’s population has antibodies for the new coronavirus? Even in Spain – one of the very worst-hit countrie…
@JohnDrakeCooper @autothrottle There’s dozens of them but this recent one from Spain will do (it’s the first one I found). 250,000 confirmed cases 5% population have antibodies = 2.75m people https://t.co/lvqHvM3TaW
RT @jvillacastin: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/CeAI…
RT @jvillacastin: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/CeAI…
RT @jvillacastin: Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/CeAI…
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/CeAIqTTove
Si consideramos que la sensibilidad del test IgM es del 80% (es decir, P(A|D) = 0.8), que está en torno a las cifras de sensibilidad que se manejaron en el estudio de seroprevalencia del ISCiii/INE para IgM (https://t.co/FWkqzF3tOD), entonces: X = 100/0.8
@mjoanasa @alchemytoday Another point is the asymptomatic proportion. They are thin on details, but say majority should be asymptomatic. The Spanish serological study says about 30%. Except for population age differences, the ratio should be similar, no?
@cc2me3 @Newsweek Herd immunity is not obtainable with a corona virus. Especially this one. That is known and settled. Move on..... this is just one of several solid studies that found the same thing. https://t.co/vAu43GvFE4
The fact that there are symptoms coincedent w/ + test isn't especially convincing. Most people that think they have COVID-19 based on symptoms don't (https://t.co/df26LFaVUq). Finally, re-infections will almost inevitably occur given what we know about cor
@Zachxeon depends on time from seroconversion. two weeks later it's less than 10% missing after taking into account sensibility, and antibodies take months to really go away https://t.co/XdUuTrMeco https://t.co/dA6Ge9Y1ms
Lembrando que após o colapso no sistema de saúde na Espanha, apenas 5% da população havia tido contato com o coronavírus. https://t.co/fSrOL75fqg
RT @DiseaseEcology: What fraction of populations are exposed in huge #COVID19 epidemics & what drives transmission & exposure? Serosurvey…
@Lukkezen Ja. Voorzover ik cijfers heb kunnen controleren is de seroprevalentie in Madrid vergelijkbaar of hoger dan in Stockholm en is Stockholm een van de ergst getroffen gebieden in Zweden. Hier Spaanse studie: https://t.co/fg0EunrqOr
@agwood It's also interesting to me that so relatively few people seem to have antibodies even in places with high infection rates. This paper in @TheLancet a few weeks ago was an eye-opener. https://t.co/LfJ0KsqZam
"Europe’s largest effort to identify people who have been infected by the new coronavirus has found... " Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/4aiZO42XEy
@reverseyourmind @apyretyque @santafi77 @CovidSolidarit1 @CuteCadavra @katia_lekarski https://t.co/Hr1gDTTMU6 https://t.co/h1j4ktQ7X9 Article tout récent: https://t.co/LOcpyBQnt1 (sans oublié tout ce qui est sorti avant en suède, en suisse et l'étude à sor
@RambaAyca @IngoHeinscher @SHomburg @c_drosten Wie viele sind denn 2%-3% von 82 Millionen? Wäre Dir das lieber, wenn wir die erst beerdigen müssten um dann zu erkennen, das Gegenmaßnahmen sinnvoll sind? Das Geschrei von Dir würde ich dann sehen wollen, wi
@JanoschKorell @IngoHeinscher @SHomburg @c_drosten Aber wir können es schätzen. Wie viel sind denn 2%-3% von 82 Millionen? https://t.co/PrlHwjTLRI
@AwokeKnowing @jeremyphoward @zeynep Last comment; They randomly went to houses in Geneva and Spain and many other cities/countries. These information are in those papers. E.g. https://t.co/cKyYpoYleE Spend some time to read.
7月6日にLancet誌電子版に掲載された原文はこちら。 数字打つの面倒くさいからやめた\( 'ω')/ https://t.co/s7ShVlp2IA
@4lpha0ne @Nele90 @030Berlinerin @maximal1996 Doch, gab es zum Beispiel in Spanien. https://t.co/WXaRTzN9CR
@Sushi86 @Nele90 @DonnyJepp4 @la_etzad @anti_Extrema Jetzt einfach mal nach Spanien schauen. Infektionssterberate bei 2%-3%. Das ist die doppelte bis dreifache Menge an Todedfällen als wir sonst haben. Haben wir Bock auf 2-3 Mio zusätzliche Tote? Ich glaub
RT @AlanHall1979: @MartinBevan15 @StevenW69808657 @Love_Nature2020 Do you know asymptomatic means. https://t.co/8E0ghNj62Y
RT @DrDWhitlowDC: @jeremyfaust The study in Spain at the beginning of July is pretty convincing in how we might interpret the implications…
RT @laoneill111: Most of Spanish have no antibodies even in hotspots. 5·0% test positive for antibody overall. c10% in Madrid. Ireland like…
الإصابة للمرة الثانية.
@HonHonHonHon @MichaelRosenYes @nkquakyi @BarbaraNtumy Well she’s talking nonsense, a recent study in Spain shows antibody persistence is about 5% after 3 months in those infected. Herd immunity is probably not possible and it casts doubt on the viability
US & Spanish research suggests that due to undocumented/ untested symptomatic & undetected asymptomatic cases, the real number of #coronavirus cases could be about 10 times official recorded number of cases https://t.co/0NPNuUbbfa https://t.co/O7
RT @Alejandro_Ibago: @SurvivedThisFar @PeterHotez @TXMedCenter @TheLancet Yes (14% of them). It is exactly one of the key points of this r…
@joshuasweitz Also, seroprevalence generally higher in older children, e.g. https://t.co/4uxriAweDZ, https://t.co/dFxeJhzmdo
@NoMiSD1 @StefFun @RS_Eng_Brain Bin nicht sicher, ob man das daraus herauslesen kann. Siehe Relative performance of point-of-care test: https://t.co/OW6WToOz8y https://t.co/2SQRWqTs1Z
RT @DrDWhitlowDC: @jeremyfaust The study in Spain at the beginning of July is pretty convincing in how we might interpret the implications…
@Cholega Hay que leer el estudio para entender el muestreo, la población objetivo, los instrumentos utilizados, sensibilidad y errores tipo I y II de pruebas. Aquí un ejemplo de España. Seroprevalencia 5%, ~13% en Madrid https://t.co/mroJZWV5FL https://t.c
@DiseaseEcology @mlipsitch @mugecevik Very low counts + estimation of P(severe|detected covid), not P(severe|infection). In Spain, seroprevalence higher in older children https://t.co/1iHcW8uvIX while hospitalization rates similar https://t.co/2sdEbiIQ2m,
@sujayjaswa @EricTopol What population immunity? There is no evidence having #COVID19 gives you immunity to it. Spain tested the entire nation and only 5% of people had antibodies. Another study found asymptomatic people did not retain antibodies. https://
RT @donni__69: Afortunadamente en España tenemos un fantástico estudio de seroprevalencia (porcentaje de gente que tiene anticuerpos porque…
RT @donni__69: Afortunadamente en España tenemos un fantástico estudio de seroprevalencia (porcentaje de gente que tiene anticuerpos porque…
Afortunadamente en España tenemos un fantástico estudio de seroprevalencia (porcentaje de gente que tiene anticuerpos porque ha pasado la infección) realizado por @sanidadgob entre marzo-mayo de 2020. Los resultados se han publicado en The Lancet https://t
@jeremyfaust The study in Spain at the beginning of July is pretty convincing in how we might interpret the implications of trying to achieve herd immunity. It would come at a great cost of many lives and overburdening the health care system. https://t.co/
@EdwardGoldste16 @mlipsitch @mugecevik Spain data: case incidence vs serology showing 5-14 are ~2.5x less likely to be detected as case than 15-39, likely due to asymptomatic infection. Hospit. diffs even larger. Serology: https://t.co/bcNlfoLnk2 Pop: htt
Bazı ülkeler #COVID19 tarama çalışmalarını ciddiye alıyor. Bu İspanya’nın hazırladığı son sero epidemiyolojik çalışma raporu: https://t.co/4qOCjOAwlm
@cabville @BierleinPar @BallouxFrancois I gave you references to precise data sources. Madrid, and Spain in general, antibody studies. If your opinions are data-based, you know about them. If not: https://t.co/G4u0ooXj92 Link to article (embedded) regardin
RT @ferduende: SARS-CoV-2 seroprevalence in Spain 5% nationwide, 11% in Madrid 😰😰😰
RT @DiseaseEcology: What fraction of populations are exposed in huge #COVID19 epidemics & what drives transmission & exposure? Serosurvey…
RT @EricTopol: New @TheLancet: a seroprevalence study of over 60,000 people in Spain. 5% with marked geographic heterogeneity. 33% infectio…
【7/22JC】Pollán M, et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study [published online ahead of print, 2020 Jul 3]. Lancet. 2020;S0140-6736(20)31483-5. doi:10.1016/S0140-6736(20)31483-5 https://t.
RT @cyberdoc60: Vergesst Herdenimmunität In Spanien wo #COVID19de-19 gewütet hat sind gerade mal 5 % mit AK Nachweis immun https://t.co/…
@12FreeBeer @MarionKoopmans I suggest you read the actual report on spain's serology as published in the Lancet, the part in the screenshot below is from pg 3 (See if you can spot the S-based test kit information and compare it to the initial post by Prof
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study - The Lancet https://t.co/wnZwjNSHhe
RT @quequesierra: @PabloCabezudo @JuanPedroReyes https://t.co/HS2y6hjhnm unos 2,3 millones
RT @quequesierra: @PabloCabezudo @JuanPedroReyes https://t.co/HS2y6hjhnm unos 2,3 millones
@nickcane22 @CallumGR1874 @LaraCrabb Cause he clearly said your last tweet, not that he'd trawled through your timeline. Ah...herd immunity. That old arguement https://t.co/cUTbU6SRwJ
RT @NuritBaytch: @Musikeando @AlexBerenson except Alex keep claiming Sweden’s recent decline in new cases is due to herd immunity, and sero…
@Musikeando @AlexBerenson except Alex keep claiming Sweden’s recent decline in new cases is due to herd immunity, and seroprevalence in Sweden is at 6%: https://t.co/CRa2tXhcyH in Barcelona, it’s at 7%: https://t.co/C1ztohY8hN
RT @DiseaseEcology: Answer: Because it is easy. Instead of designing proper study w/ randomized sample (see e.g. https://t.co/df26LETl2S),…
@michaelmina_lab @mboyle1959 Certainly seems plausible through vaccine, but this study seems to dismantle notions of the herd immunity route. *Please note, I'm not an expert at all, just happened to read this article. https://t.co/BCOyI4tOIX
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
مدير #مستشفي_حميات_دمنهور يعلن اصابته للمرة الثانية، هذا الموضوع تكرر كثيرا مما يثير الشكوك حول جدوى التطعيمات القادمة. في بداية ظهور الكورونا تخوفت من ذلك. هذه دراسة أسبانية بخصوص هذه النقطة تم نشرها في لانست منذ اسبوعين تقريبا https://t.co/4GGz83DBC
@virtualdxs @mholt6 Recent studies are showing that antibodies may last just a few weeks, so there's that https://t.co/f7IoB8aonS
Si això és cert, la mortalitat a Espanya seria de poc més de l'1% (28.500 persones). Ara bé, tenint en compte les patologies prèvies, segurament el nombre de morts atribuïbles únicament i exclusiva al virus, deu baixar força. Per tant, la taxa de mortalita
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
RT @laoneill111: Most of Spanish have no antibodies even in hotspots. 5·0% test positive for antibody overall. c10% in Madrid. Ireland like…
@isabelrodbar @callin_bull Can you explain how they can be interpreted safely? These samples are from cholesterol etc. screening & thus are highly non-representative of pop. Also why can't national surveys can't be done very rigorously? We already hav
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
There was already some doubt about herd immunity. https://t.co/0qO0D5AJhs As we go further we learn more.
@Jonnyb313313 @io_Majed @spectatorindex You don’t believe mainstream media? Fine. Read the damn study yourself and then make an opinion: https://t.co/81G8qP9Kbg
RT @DiseaseEcology: Answer: Because it is easy. Instead of designing proper study w/ randomized sample (see e.g. https://t.co/df26LETl2S),…
@Rapatauxx @FrankfurtZack Die schwedischen Sterbefälle kannst Du von der Quelle, die Du gepostet hast, direkt runterladen: https://t.co/YmlmOCqM5A IFR kannst Du Dir mal am Beispiel von Spanien ansehen. 👇 https://t.co/PrlHwjTLRI https://t.co/sR5nnCkIKX
RT @DrEricDing: 2) “Most PCR-confirmed cases have detectable antibodies, but a substantial proportion of people with symptoms compatible wi…
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
@callitmeepmorp @Polski_Suzeren @OlusolaSijola @56781123P @mumbles_j As a courtesy to all https://t.co/5GJrQ8Shon
@rebelwrapt @BarryHebes @p_a_kirwan @Barb63848382 @hankt72 @vancemurphy @TwitterSafety Have you gone back and read the scientific journal articles themselves? If you had, you’d see that there’s little consensus on if herd immunity is anywhere imminent. Mo
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
RT @joethebrew: En tot cas, cal recordar que hi ha una escletxa enorme entre: -el nombre de casos detectats -el nombre de casos reals >5%…
@XavierHugonet @Fraslin https://t.co/rjVLgjSxFV Article sur l'étude espagnole parue dans The Lancet: https://t.co/Hr1gDTTMU6
@ravirajanpawar @ranajig @Tinni_Aphrodite coolio, maybe we can meet up after this pandemic is over. Would probably take quite a long time for this to be over. Even herd immunity is not a thing https://t.co/uPIxBDop2K
RT @shirishag75: @bulletmanV @Simply_Krishna umm.. then you haven't seen the spanish study covered in lancet https://t.co/uPIxBDop2K
@bulletmanV @Simply_Krishna umm.. then you haven't seen the spanish study covered in lancet https://t.co/uPIxBDop2K
Prevalence of SARS-CoV-2 in Spain 🇪🇸 (ENE-COVID): a nationwide, population-based seroepidemiological study Done between April and May, published in July https://t.co/D9e13sRzPl
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study https://t.co/69VgiyY6M4
RT @DiseaseEcology: Answer: Because it is easy. Instead of designing proper study w/ randomized sample (see e.g. https://t.co/df26LETl2S),…